- Home
- BCYC vs CGC Comparison
BCYC vs CGC Comparison
Compare BCYC & CGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BCYC | CGC |
|---|---|---|
| Founded | 2009 | N/A |
| Country | United Kingdom | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Pharmaceuticals and Biotechnology |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 456.4M | 404.3M |
| IPO Year | 2019 | 2023 |
Fundamental Metrics
Financial Performance| Metric | BCYC | CGC |
|---|---|---|
| Price | $5.68 | $1.09 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 10 | 2 |
| Target Price | ★ $19.10 | N/A |
| AVG Volume (30 Days) | 442.2K | ★ 9.6M |
| Earning Date | 01-01-0001 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 42.91 | 36.75 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $12,759,000.00 |
| Revenue This Year | N/A | $8.04 |
| Revenue Next Year | N/A | $4.17 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.03 | $0.77 |
| 52 Week High | $10.89 | $2.38 |
Technical Indicators
Market Signals| Indicator | BCYC | CGC |
|---|---|---|
| Relative Strength Index (RSI) | 45.90 | 43.44 |
| Support Level | $5.03 | $1.01 |
| Resistance Level | $5.90 | $1.25 |
| Average True Range (ATR) | 0.30 | 0.05 |
| MACD | 0.06 | -0.00 |
| Stochastic Oscillator | 72.83 | 35.00 |
Price Performance
Historical ComparisonAbout BCYC Bicycle Therapeutics plc
Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.
About CGC Canopy Growth Corporation
Canopy Growth Corp, cultivates and sells medicinal and recreational cannabis and hemp through a portfolio of brands that include Doja, LivRelief, Ace Valley, Deep Space, and others. The Company is engaged in reportable segments namely: Canada cannabis, International markets cannabis, Storz & Bickel, and This Works. The company generates maximum revenue from Canadian cannabis.